{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:47:50Z","timestamp":1768808870767,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":6920,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1111\/j.1538-7836.2004.00552.x","type":"journal-article","created":{"date-parts":[[2004,1,9]],"date-time":"2004-01-09T04:27:50Z","timestamp":1073622470000},"page":"111-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Factors influencing therapeutic efficacy and the host immune response to helper\u2010dependent adenoviral gene therapy in hemophilia A mice"],"prefix":"10.1016","volume":"2","author":[{"given":"B.D.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.X.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.E.M.","family":"Rawle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tinlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mckinven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.L.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lillicrap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00062752-199502050-00007","article-title":"Factor VIII inhibitors","volume":"2","author":"Hoyer","year":"1995","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0015","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1089\/10430340152528147","article-title":"Adenovirus\u2010mediated factor VIII gene expression results in attenuated anti\u2010factor VIII\u2010specific immunity in hemophilia A mice compared with factor VIII protein infusion","volume":"12","author":"Bristol","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0020","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0958-1669(95)80097-2","article-title":"The use of adenoviral vectors for gene therapy and gene transferin vivo","volume":"6","author":"Bramson","year":"1995","journal-title":"Curr Opin Biotechnol"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0025","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood.V91.9.3273","article-title":"Sustained phenotypic correction of murine hemophilia A byin vivo gene therapy","volume":"91","author":"Connelly","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0030","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1089\/10430349950017473","article-title":"In vivo evaluation of an adenoviral vector encoding canine factor VIII: high\u2010level, sustained expression in hemophiliac mice","volume":"10","author":"Gallo\u2010Penn","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0035","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1182\/blood.V88.10.3846.bloodjournal88103846","article-title":"Complete short\u2010term correction of canine hemophilia A byin vivo gene therapy","volume":"88","author":"Connelly","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood.V97.1.107","article-title":"Systemic delivery of an adenoviral vector encoding canine factor VIII results in short\u2010term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs","volume":"97","author":"Gallo\u2010Penn","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0045","doi-asserted-by":"crossref","first-page":"13565","DOI":"10.1073\/pnas.93.24.13565","article-title":"A helper\u2010dependent adenovirus vector system: removal of helper virus by Cre\u2010mediated excision of the viral packaging signal","volume":"93","author":"Parks","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF03402113","article-title":"Toxicity associated with repeated administration of first\u2010generation adenovirus vectors does not occur with a helper\u2010dependent vector","volume":"6","author":"O'Neal","year":"2000","journal-title":"Mol Med"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0055","first-page":"454","article-title":"High\u2010capacity \u2018gutless\u2019 adenoviral vectors","volume":"3","author":"Kochanek","year":"2001","journal-title":"Curr Opin Mol Ther"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0060","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood.V95.3.820.003k32_820_828","article-title":"Sustained high\u2010level expression of full\u2010length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector","volume":"95","author":"Balague","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/mthe.2001.0510","article-title":"Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector","volume":"5","author":"Reddy","year":"2002","journal-title":"Mol Ther"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0070","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2002-03-0823","article-title":"Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high\u2010capacity adenoviral vectors","volume":"101","author":"Chuah","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0075","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1089\/10430340260201671","article-title":"The canine factor VIII 3\u2032\u2010untranslated region and a concatemeric hepatocyte nuclear factor 1 regulatory element enhance factor VIII transgene expressionin vivo","volume":"13","author":"Notley","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0080","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1073\/pnas.97.3.1002","article-title":"Optimization of the helper\u2010dependent adenovirus system for production and potencyin vivo","volume":"97","author":"Sandig","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0085","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/sj.gt.3300995","article-title":"Use of helper\u2010dependent adenoviral vectors of alternative serotypes permits repeat vector administration","volume":"6","author":"Parks","year":"1999","journal-title":"Gene Ther"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0095","first-page":"612","article-title":"Proceedings: a more uniform measurement of factor VIII inhibitors","volume":"34","author":"Kasper","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0378-1119(90)90176-R","article-title":"RNA template\u2010specific polymerase chain reaction (RS\u2010PCR): a novel strategy to reduce dramatically false positives","volume":"91","author":"Shuldiner","year":"1990","journal-title":"Gene"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/1566523013348508","article-title":"Viral vector\u2010mediated gene therapy for hemophilia","volume":"1","author":"VandenDriessche","year":"2001","journal-title":"Curr Gene Ther"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/10430340152712683","article-title":"The release of inflammatory cytokines from human peripheral blood mononuclear cellsin vitro following exposure to adenovirus variants and capsid","volume":"13","author":"Higginbotham","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/10430340152712700","article-title":"Effect of blood collection technique in mice on clinical pathology parameters","volume":"13","author":"Schnell","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0120","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1089\/10430349950017455","article-title":"Use of a liver\u2010specific promoter reduces immune response to the transgene in adenoviral vectors","volume":"10","author":"Pastore","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/smim.2000.0232","article-title":"Self\u2010tolerance: context dependent tuning of T cell antigen recognition","volume":"12","author":"Grossman","year":"2000","journal-title":"Semin Immunol"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.gt.3300412","article-title":"Adenovirus\u2010mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression","volume":"4","author":"Michou","year":"1997","journal-title":"Gene Ther"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0135","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1128\/JVI.73.6.4755-4766.1999","article-title":"Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus\u2010mediated transgene expression in immune\u2010competent mice","volume":"73","author":"Schowalter","year":"1999","journal-title":"J Virol"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0140","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1128\/JVI.75.10.4540-4550.2001","article-title":"Variation in adenovirus transgene expression between BALB\/c and C57BL\/6 mice is associated with differences in interleukin\u201012 and gamma interferon production and NK cell activation","volume":"75","author":"Peng","year":"2001","journal-title":"J Virol"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0145","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/sj.gt.3301409","article-title":"Intravenous administration of an E1\/E3\u2010deleted adenoviral vector induces tolerance to factor IX in C57BL\/6 mice","volume":"8","author":"Fields","year":"2001","journal-title":"Gene Ther"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/j.1538-7836.2003.tb03469.x","article-title":"The use of three hemophilia A mouse models to illustrate strain\u2010specific differences in immune responses to FVIII protein replacement via protein infusion or adenoviral gene therapy","author":"Rawle","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/mthe.2000.0120","article-title":"In vivo dose threshold effect of adenovirus\u2010mediated factor VIII gene therapy in hemophiliac mice","volume":"2","author":"Bristol","year":"2000","journal-title":"Mol Ther"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0160","article-title":"Helper\u2010dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A","author":"Brown","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00552.x_bb0165","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1182\/blood-2002-07-2146","article-title":"Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen\u2010presenting cells","volume":"101","author":"De Geest","year":"2003","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2004.00552.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622177998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622177998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2004.00552.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:29:02Z","timestamp":1761532142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622177998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S1538783622177998"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00552.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors influencing therapeutic efficacy and the host immune response to helper\u2010dependent adenoviral gene therapy in hemophilia A mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00552.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}